Alvotech
Alvotech (ALVO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ALVO · as of Mar 31, 2025
Ownership Breakdown
50
Institutional Holders
▲ 5 vs Q4
$158.90M
Total Inst. Value
▼ $40.71M vs Q4
312.05M
Shares Outstanding
freeFloat 36.56%
16.64M
13F Shares Held
▲ 1.25M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ALVO largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC biological products, (no diagnostic substances) | 4.19M | 1.49% | 1.49% | $40.31B | May 9, 2025 | ▲ 995.5K |
BRACEBRIDGE CAPITAL, LLC biological products, (no diagnostic substances) | 2.71M | 96.20% | 96.20% | $26.16B | May 15, 2025 | — held |
OAKTREE CAPITAL MANAGEMENT LP biological products, (no diagnostic substances) | 1.87M | 66.44% | 66.44% | $18.07B | May 15, 2025 | ▼ 57.2K |
PRICE T ROWE ASSOCIATES INC /MD/ biological products, (no diagnostic substances) | 1.40M | 49.83% | 49.83% | $13.55B | May 14, 2025 | NEW |
LITTLEJOHN & CO LLC biological products, (no diagnostic substances) | 1.32M | 46.88% | 46.88% | $12.75B | May 13, 2025 | — held |
POINTSTATE CAPITAL LP biological products, (no diagnostic substances) | 1.17M | 41.76% | 41.76% | $11.36B | May 15, 2025 | ▼ 67.0K |
MORGAN STANLEY biological products, (no diagnostic substances) | 1.01M | 36.00% | 36.00% | $9.79B | May 15, 2025 | ▼ 469.7K |
BLACKROCK, INC. biological products, (no diagnostic substances) | 843.3K | 29.99% | 29.99% | $8.16B | May 2, 2025 | ▲ 4.1K |
LEGAL & GENERAL GROUP PLC biological products, (no diagnostic substances) | 562.4K | 20.00% | 20.00% | $5.37B | May 15, 2025 | ▼ 13.8K |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 228.7K | 8.13% | 8.13% | $2.21B | May 13, 2025 | ▲ 11.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
19
Increased
+1.09M shares7
New Positions
first time holders14
Decreased
−1.24M shares0
Sold Out
fully exitedNet shares change (top 50)
150.8K
+1.09M / −1.24M
Net new holders
+12
7 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ALVO insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Alvotech (ALVO) is primarily owned by institutional investors, who hold approximately 5.3% of total shares outstanding. Company insiders own approximately 63.44%, while retail and public investors account for the remaining 31.23%.
The largest institutional shareholder of Alvotech is VANGUARD GROUP INC, holding approximately 4.19 million shares — equal to 1.49% of outstanding shares — as of March 31, 2025.
A total of 50 institutional investors currently hold ALVO stock, with a combined institutional value of approximately $158,899,776 as of the most recent 13F filing period.
Frequently asked questions
ALVO ownershipAlvotech (ALVO) is primarily owned by institutional investors, who hold approximately 5.3% of shares. The largest shareholder is VANGUARD GROUP INC with a 1.49% stake. Company insiders hold 63.44%. Data sourced from SEC Form 13F as of March 31, 2025.